types of virtual currency- Top Knowledge

The European Central Bank cut interest rates by 25 basis points, warning that economic growth will slow down. The European Central Bank cut interest rates by 25 basis points to 3%, and warned that economic growth will be weaker than its previous forecast. This is the fourth time that the European Central Bank has cut interest rates since June, bringing the benchmark interest rate to its lowest level since March 2023. At the same time, the European Central Bank warned that the euro zone economy will only grow by 1.1% in 2025, lower than its forecast of 1.3% in September. It was widely expected that the European Central Bank would cut interest rates. Investors expect that the European Central Bank will cut interest rates more than the Federal Reserve next year, because it is widely expected that the economic growth of the euro zone will lag behind that of the United States. The euro zone's export-dependent economy is also vulnerable to Trump's threat to impose tariffs of up to 20% on all American imports.Xinxuan Group: The sales volume of the "Xin Huo Plan" is nearly 2 billion yuan, and Xinxuan Group disclosed the sales data of the live broadcast of the "Xin Huo Plan" in Shanxi Station. Statistics show that the two live broadcasts brought a total of 3.67 million orders, helping Shanxi specialty products with sales exceeding 180 million yuan to go nationwide. It is understood that this activity is guided by the Shanxi Provincial Department of Commerce. According to the disclosure, Xinxuan Group's "Xin Huo Plan" went to the whole country to carry out a number of live broadcast activities to help farmers, with sales of nearly 2 billion yuan. In addition, Xinxuan Group has donated a total of nearly 400 million yuan to the society. (Sina Technology)Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).

Russian central bank: Russia's current account surplus in November was $3.2 billion.COMEX silver fell 1.00% in the day and is now quoted at $32.63 per ounce.China Chengtong and China Yizhong set up an enterprise management center with a capital contribution of 6.25 billion yuan. According to Tianyancha App, Zhongcheng (Beijing) Enterprise Management Center (Limited Partnership) was recently established. The executive partner is Yizhong Group Sunac Technology Development Co., Ltd., with a capital contribution of 6.25 billion yuan. The business scope is enterprise management and enterprise management consulting. It is owned by China Chengtong's Beijing Chengtong Capital Investment Co., Ltd., China Yizhong Group Co., Ltd. and its subsidiary Sunac Technology Development Co., Ltd.

Western Securities and others set up a parent fund management partnership with a capital contribution of 2 billion yuan. According to Tianyancha APP, recently, Xiaogan Xizheng Gaochuang Industrial Investment Parent Fund Management Partnership (Limited Partnership) was established with a capital contribution of 2 billion yuan. Its business scope includes: private equity investment fund management, venture capital fund management services, etc. Tianyancha's equity penetration shows that the enterprise is jointly held by Western Advantage Capital Investment Co., Ltd., a wholly-owned subsidiary of Western Securities, and Xiaogan Gaochuang Investment Co., Ltd.Trade union representative: STELLANTIS told us that the output of Italy in 2025 will be similar to this year, about 500,000 vehicles.Huachuang Securities: It was first rated as "recommended" by Zangge Mining, with a target price of 33.3 yuan. Huachuang Securities Research Report pointed out that Zangge Mining (000408.SZ) is an important producer of potassium lithium salt and copper in China, with a high dividend return to shareholders. The company actively arranges high-quality potash resources at home and abroad: three major projects, namely, Heibei potash mine in Dalangtan, Alkali-Shishan potash mine and the eastern part of deep brine potash mine in Xiaoliangshan-Dafengshan area, are steadily promoted in China, with a total exploration right of 1,400 square kilometers; Overseas has signed a potash exploration agreement with Laos. At present, the exploration report and potash mine reserve certificate have been obtained. It is estimated that the total amount of potassium chloride resources in Setani County and Ba 'e County is 984 million tons. It is estimated that the output of the first phase of potassium chloride project will be 1 million tons/year, and the scale of potassium chloride production is expected to double in the future. The company is an important manufacturer of potassium and lithium in China, and Julong Copper is expected to inject strong kinetic energy into the company's growth. Considering that Mamicho Mining has not been consolidated at present, it is estimated that the company will realize a net profit of 25.0/27.7/4.29 billion yuan in 24-26 years, which is -27%, +11% and +54.9% respectively. In 2025, it can be compared with the company's average valuation of 19 times, giving the company a valuation of 19 times in 2025, corresponding to the target price of 33.3 yuan, covering for the first time and giving a "recommended" rating.